CA2151142C - Ligand glycoproteique pour la p-selectine et ses modes d'utilisation - Google Patents

Ligand glycoproteique pour la p-selectine et ses modes d'utilisation Download PDF

Info

Publication number
CA2151142C
CA2151142C CA002151142A CA2151142A CA2151142C CA 2151142 C CA2151142 C CA 2151142C CA 002151142 A CA002151142 A CA 002151142A CA 2151142 A CA2151142 A CA 2151142A CA 2151142 C CA2151142 C CA 2151142C
Authority
CA
Canada
Prior art keywords
selectin
ligand
cells
binding
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002151142A
Other languages
English (en)
Other versions
CA2151142A1 (fr
Inventor
Richard D. Cummings
Kevin L. Moore
Rodger P. Mcever
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Oklahoma
Original Assignee
University of Oklahoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Oklahoma filed Critical University of Oklahoma
Publication of CA2151142A1 publication Critical patent/CA2151142A1/fr
Application granted granted Critical
Publication of CA2151142C publication Critical patent/CA2151142C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CA002151142A 1992-11-16 1993-11-16 Ligand glycoproteique pour la p-selectine et ses modes d'utilisation Expired - Fee Related CA2151142C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97655292A 1992-11-16 1992-11-16
US976,552 1992-11-16
PCT/US1993/011129 WO1994011498A1 (fr) 1992-11-16 1993-11-16 Ligand clycoproteique pour la p-selectine et son procede d'utilisation

Publications (2)

Publication Number Publication Date
CA2151142A1 CA2151142A1 (fr) 1994-05-26
CA2151142C true CA2151142C (fr) 2001-10-02

Family

ID=25524217

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002151142A Expired - Fee Related CA2151142C (fr) 1992-11-16 1993-11-16 Ligand glycoproteique pour la p-selectine et ses modes d'utilisation

Country Status (4)

Country Link
EP (1) EP0668907A1 (fr)
AU (1) AU681369B2 (fr)
CA (1) CA2151142C (fr)
WO (1) WO1994011498A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464778A (en) * 1989-03-08 1995-11-07 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for P-selectin and methods of use thereof
US6124267A (en) * 1991-02-05 2000-09-26 Southpac Trust Internationals, Inc. O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
US6309639B1 (en) 1991-02-05 2001-10-30 The Board Of Regents Of The University Of Oklahoma Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
US5648458A (en) * 1992-05-06 1997-07-15 Affymax Technologies N.V. Peptides and compounds that bind to ELAM-1
US5728802A (en) * 1992-05-06 1998-03-17 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1)
US5643873A (en) * 1992-05-06 1997-07-01 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
DE69333346T2 (de) * 1992-10-23 2004-10-07 Inst Genetics Llc Neuartiges p- selectin ligandenprotein
US6277975B1 (en) 1992-10-23 2001-08-21 Genetics Institute, Inc. Fusions of P-selectin ligand protein and polynucleotides encoding same
US5843707A (en) * 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
WO1995030001A2 (fr) * 1994-04-28 1995-11-09 Genetics Institute, Inc. Nouvelle proteine ligand de p-selectine
CZ401497A3 (cs) * 1995-06-14 1998-07-15 The General Hospital Corporation P-selektinové ligandy a příbuzné molekuly a způsoby
EP1428832A3 (fr) * 1995-08-03 2004-09-22 The Board of Regents for the University of Oklahoma Peptides et O-glycanes inhibiteurs de l'inflammation induite par la sélectine
EP0850243B1 (fr) * 1995-08-03 2003-10-08 Board Of Regents Of The University Of Oklahoma o-glycanes inhibiteurs de l'inflammation induite par la selectine
US6841543B1 (en) 1996-01-31 2005-01-11 President And Fellows Of Harvard College Methods of inhibiting production of T helper type 2 cytokines in human immune cells
WO1999043834A2 (fr) * 1998-02-27 1999-09-02 Genetics Institute, Inc. Proteine constituant un ligand de la p-selectine et proteines de fusion tetrameriques
US20030143662A1 (en) 1998-06-16 2003-07-31 Cummings Richard D. Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
DE69934890D1 (de) 1998-06-16 2007-03-08 Univ Oklahoma Glykosulfopeptide und verfahren zu deren herstellung und deren verwendung
US7223845B2 (en) 1998-06-16 2007-05-29 The Board Of Regents Of The University Of Oklahoma Synthetic glycosulfopeptides and methods of synthesis thereof
MXPA01004310A (es) * 1998-10-30 2003-06-06 Cbr Lab Inc Inhibicion de diferenciacion de celulas t citotoxicas mediante antagonistas de ligando de p-selectina (psgl).
ATE321570T1 (de) * 2000-05-19 2006-04-15 Blood Res Center Verfahren zur behandlung von hämostatischen störungen durch lösliches p-selectin
WO2002089819A1 (fr) * 2001-05-07 2002-11-14 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Glycoconjugues et utilisations de ceux-ci
EP3568159A4 (fr) 2017-01-11 2020-08-05 Bristol-Myers Squibb Company Antagonistes de psgl-1 et leurs utilisations
KR102715540B1 (ko) 2017-03-14 2024-10-08 파이브 프라임 테라퓨틱스, 인크. 산성 pH에서 VISTA에 결합하는 항체
BR112020019083A2 (pt) 2018-03-21 2020-12-29 Five Prime Therapeutics, Inc. Anticorpos, ácido nucleico, composições, célula e métodos para preparar um anticorpo, para tratar câncer, para tratar uma doença infecciosa, para tratar uma inflamação, para a identificação de um anticorpo, para melhorar a eficácia antitumoral de um anticorpo, para melhorar a farmacocinética de um anticorpo, para selecionar um anticorpo, para melhorar a eficácia de anticorpos, para isolar anticorpos, para detectar vista em uma amostra e para tratar câncer
BR112021000303A2 (pt) 2018-07-11 2021-04-13 Five Prime Therapeutics, Inc. Anticorpos que se ligam a vista em ph ácido

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2067250C (fr) * 1989-10-20 2008-06-17 Bruce Furie Inhibition de la fixation cellulaire a mediation padgem
DK0714912T3 (da) * 1990-07-17 2003-02-03 Univ Oklahoma Funktionelt aktive selektin-deriverede peptider og ligander for GMP-140
CA2105997A1 (fr) * 1991-03-11 1992-09-12 Bruce Furie Methode d'inhibition d'interactions par l'intermediaire d'un ligand padgem, grace a un inhibiteur renfermant de l'acide sialique avec une liaison 2,6

Also Published As

Publication number Publication date
EP0668907A1 (fr) 1995-08-30
CA2151142A1 (fr) 1994-05-26
AU5727594A (en) 1994-06-08
WO1994011498A1 (fr) 1994-05-26
AU681369B2 (en) 1997-08-28

Similar Documents

Publication Publication Date Title
CA2151142C (fr) Ligand glycoproteique pour la p-selectine et ses modes d'utilisation
US5880091A (en) Glycoprotein ligand for P-selectin and methods of use thereof
US6309639B1 (en) Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
AU660627B2 (en) Functionally active selectin-derived peptide for GMP-140
US5198424A (en) Functionally active selectin-derived peptides
US6124267A (en) O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
AU723262B2 (en) Peptide and O-glycan inhibitors of selectin mediated inflammation
EP0602194A1 (fr) Inhibiteurs peptidiques d'inflammation presentant une mediation par les selectines
WO1994014836A1 (fr) Inhibiteurs peptidiques de liaison de selectine
WO1992016612A2 (fr) Procede d'inhibition d'interactions induites par padgem au moyen d'un inhibiteur comprenant un constituant d'acide 2,6 sialique
WO1994005314A1 (fr) Inhibiteurs peptidiques de l'adhesion des leucocytes
EP0656904A1 (fr) Peptides inhibiteurs de la liaison de selectine
Cochrane et al. Cellular and Molecular Mechanisms of Inflammation: Vascular Adhesion Molecules
EP1245575A2 (fr) Peptides fonctionellement actifs dérivés de sélectine et ligand pour GMP140
EP1428832A2 (fr) Peptides et O-glycanes inhibiteurs de l'inflammation induite par la sélectine
HK1066813A (en) Peptide and o-glycan inhibitors of selectin mediated inflammation

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed